Immutep (IMMP) Exchange Rate Effect (2016 - 2024)
Immutep's (IMMP) quarterly Exchange Rate Effect came in at -$186541.5 in Q2 2024, up 5.72% YoY from -$176447.8 in Q3 2023, and up 5.72% on a QoQ basis from -$197860.1 in Q2 2023.
Immutep (IMMP) Exchange Rate Effect (2016 - 2024) Analysis & Trends
Immutep (IMMP) has 4 years of Exchange Rate Effect data on file, last reported at -$186541.5 in Q2 2024.
- Quarterly Exchange Rate Effect rose 5.72% year-over-year to -$186541.5 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$49977.7 (changed N/A YoY) and the FY2025 annual result came in at $4.3 million, up 775.43% from the prior year.
- Exchange Rate Effect grew to -$186541.5 in Q2 2024, from -$197860.1 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of -$186541.5 in Q2 2024 to a low of -$197860.1 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | -797.40 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -186,541.49 |
| Jun 30, 2024 | -186,541.49 |
| Jun 30, 2023 | -197,860.09 |
| Jun 30, 2023 | -197,860.09 |
| Jun 30, 2017 | 407,726.92 |
| Jun 30, 2017 | 407,726.92 |
| Jun 30, 2016 | -73,303.03 |
| Jun 30, 2016 | -73,303.03 |